Simon N. Pimstone, Director at Xenon Pharmaceuticals Inc. (XENE), sold 42,242 shares at $36.94 ($1.6M) on 2023-03-07, disclosed to the SEC on 2023-03-09.
Open-market sale of $1.6M XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.94 | 8,242 | $304K | 19.5% |
| 2 | $36.94 | 8,242 | $304K | 19.5% |
| 3 | $37.01 | 10,990 | $407K | 26.0% |
| 4 | $37.01 | 10,990 | $407K | 26.0% |
| 5 | $37.13 | 1,618 | $60K | 3.8% |
| 6 | $37.13 | 2,160 |
| $80K |
| 5.1% |
| Total | $36.99 avg | 42,242 | $1.6M | 100% |
| Filing → |
| XENE | SELL | 2022-03-08 | $2.2M | — | Filing → |
| XENE | SELL | 2022-03-08 | $77K | — | Filing → |
| XENE | SELL | 2021-11-16 | $1.1M | — | Filing → |